The Novel Non-steroidal Selective Androgen Receptor Modulator S-101479 Has Additive Effects with Bisphosphonate, Selective Estrogen Receptor Modulator, and Parathyroid Hormone on the Bones of Osteoporotic Female Rats-Reference-Cited by-同舟云学术

The Novel Non-steroidal Selective Androgen Receptor Modulator S-101479 Has Additive Effects with Bisphosphonate, Selective Estrogen Receptor Modulator, and Parathyroid Hormone on the Bones of Osteoporotic Female Rats

Published:2012 Issue:7 Volume:35 Page:1096-1104
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Furuya Kazuyuki¹²,Yamamoto Noriko¹,Ohyabu Yuki¹,Makino Akito¹,Morikyu Teruyuki¹,Ishige Hirohide¹,Kuzutani Kazuya¹,Endo Yasuhisa²

Affiliation:

1. Central Research Laboratories, Kaken Pharmaceutical Co., Ltd.

2. Division of Applied Biology, Graduate School of Science and Technology, Kyoto Institute of Technology

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/35/7/35_b12-00054/_pdf

Reference40 articles.

1. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism

2. Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone

3. 3) Bhasin S, Woodhouse L, Casaburi R, Singh AB, Bhasin D, Berman N, Chen X, Yarasheski KE, Magliano L, Dzekov C, Dzekov J, Bross R, Phillips J, Sinha-Hikim I, Shen R, Storer TW. Testosterone dose–response relationships in healthy young men. Am. J. Physiol. Endocrinol. Metab., 281, E1172–E1181 (2001).

4. 4) Shahani S, Braga-Basaria M, Maggio M, Basaria S. Androgens and erythropoiesis: past and present. J. Endocrinol. Invest., 32, 704–716 (2009).

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of osteoporosis using a selective androgen receptor modulator ostarine in an orchiectomized rat model;Endocrine;2023-06-28

2. Treatment of osteoporosis using a selective androgen receptor modulator ostarine in an orchiectomized rat model;2023-01-03

3. LGD‐4033 and MK‐677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report;Experimental Physiology;2022-11-16

4. A combined treatment with selective androgen and estrogen receptor modulators prevents bone loss in orchiectomized rats;Journal of Endocrinological Investigation;2022-07-22

5. Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998–2021);European Journal of Medicinal Chemistry;2022-02